LBRX (LB Corp) Wutah bathi resik saben saham ing taun iki

LBRX (LB Corp) - tandha merek perusahaan

The YoY EPS dynamics demonstrate a lack of operating leverage prior to FDA approval. The success of LB Pharmaceuticals Inc (LBRX) is based on the safety of new psychotropic agents and the pace of registration. The current status is characterized by a cash burn without commercial sales. The -94.10 mark records this indicator, highlighting the biotech's total dependence on the results of clinical tests for schizophrenia drugs.

LBRX (LB Pharmaceuticals Inc) riwayat Wutah bathi saben saham ing taun lumaku saka 12.09.2025 nganti 14.11.2026

Rincian metrik keuangan lan pasar LB Pharmaceuticals Inc (LBRX)

- nilai saham lan prakiraan konsensus rega:
Rega bursa LB Pharmaceuticals, Inc.|LBRX - Prakiraan konsensus analis
- indikator valuasi pasar bisnis:
Biji pasar LB Corp|LBRX - Nilai Perusahaan
- rincian nilai buku perusahaan:
Nilai Akuntansi Saham LB Pharmaceuticals|LBRX - Nilai Buku Perusahaan|Koefisien Nilai Pasar marang Nilai Buku lbpharma.us|LBRX - Aset Agregat Perusahaan
- indikator beban utang lan likuiditas:
Utang marang Ekuitas LB Pharmaceuticals Inc|LBRX - Utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas lbpharma.us|LBRX - Gunggung utang perusahaan|Rasio utang marang aset resik LB Corp|LBRX - Utang jangka dawa perusahaan|Kewajiban jangka cendhak LB Pharmaceuticals|Rasio jangkoan perantara lbpharma.us
- indikator pendapatan resik lan kelipatan nilai:
LBRX - Bathi resik|Proyeksi bathi mangsa ngarep LB Pharmaceuticals Inc|LBRX - Rasio rega marang bathi|Pangali mangsa ngarep rega marang bathi LB Corp|LBRX - Rasio rega marang bathi tumrap wutah|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan LB Corp|LBRX - Bathi operasional EBITDA|Bathi resik saben saham (EPS TTM) LB Pharmaceuticals|LBRX - Bathi resik saben saham (EPS TTM)|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan lbpharma.us|LBRX - Wutah bathi ing taun lumaku|Prakiraan wutah bathi resik saben saham ing taun ngarep LB Pharmaceuticals Inc
- data pendapatan lan penerimaan dodolan:
LBRX - Dodolan perusahaan|Prakiraan volume dodolan LB Pharmaceuticals, Inc.|LBRX - Kapitalisasi marang pendapatan|Rasio rega marang pendapatan sing dikarepake LB Corp
Ringkesan analisis perusahaan:LB Pharmaceuticals, Inc. (LBRX)
Produk dadi lbpharma.us

The annual net income per share dynamics reflect the efficiency of LB Pharmaceuticals Inc (LBRX) drug synthesis automation amidst costly clinical trials involving psychiatrists. This indicator measures the percentage deviation of the current EPS from the previous year's value, allowing investors to assess the resilience of the business's real yield to inflationary pressure and identify the risks of purchasing the asset at historical peaks.

Pesaing utama

Kacepetan wutah bathi saben saham ing taun lumaku Alkermes PLC (ALKS)|AVDL (Avadel Pharma) - Wutah bathi ing taun lumaku|Wutah bathi resik saben saham ing taun iki atai (ATAI)|Wutah bathi ing taun lumaku GHRS|MNMD (mindmed.co) - Tambahing bathi saben saham ing taun lumaku|Wutah bathi saben saham ing taun lumaku COMPASS Pathways CMPS|Bright Minds Bio (DRUG) - Kacepetan wutah bathi saben saham ing taun lumaku|VNDA - Wutah bathi saben saham ing taun lumaku|CYBN: Wutah bathi saben saham ing taun lumaku|ANRO: Wutah bathi ing taun lumaku|NRXP (nrxpharma.com) - Wutah bathi saben saham ing taun lumaku|Wutah bathi resik saben saham ing taun iki CING|SILO: Tambahing bathi saben saham ing taun lumaku|Wutah bathi saben saham ing taun lumaku China Pharma Holdings (CPHI)|CMND: Dinamika bathi saben saham ing taun lumaku|Wutah bathi ing taun lumaku PBM (Psyence Biomedical Ltd.)|Tambahing bathi saben saham ing taun lumaku SPRC|Seelos Therapeutics, Inc. - Wutah bathi ing taun lumaku|VRPX - Wutah bathi ing taun lumaku|Karuna (KRTX) - Wutah bathi saben saham ing taun lumaku